Alzamend Neuro Inc.

NASDAQ: ALZN · Real-Time Price · USD
2.44
0.06 (2.74%)
At close: Aug 18, 2025, 3:06 PM

Alzamend Neuro Income Statement

Financials in USD. Fiscal year is May - April.
Fiscal Year Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Apr 30, 2025 Jan 31, 2025 Oct 31, 2024 Jul 31, 2024 Apr 30, 2024 Jan 31, 2024 Oct 31, 2023 Jul 31, 2023 Apr 30, 2023 Jan 31, 2023 Oct 31, 2022 Jul 31, 2022 Apr 30, 2022 Jan 31, 2022 Oct 31, 2021 Jul 31, 2021 Apr 30, 2021 Jan 31, 2021 Oct 31, 2020 Jul 31, 2020
Revenue
n/a n/a n/a n/a 76.11K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
12.69K 12.69K 12.69K 12.69K 12.69K 12.69K 12.69K 12.69K 5.32K 5.32K 5.32K 7.1K n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit
-12.69K -12.69K -12.69K -12.69K -12.69K -12.69K -12.69K -12.69K -5.32K n/a -5.32K -7.1K n/a n/a n/a n/a n/a n/a n/a n/a
Operating Income
-1.14M -1.04M -1.36M -962K -850.06K -2.66M -2.9M -3.53M -3.31M -5.42M -3.11M -3.04M -3.87M -2.56M -3.58M -2.31M -1.22M -1.12M -1.3M -1.32M
Interest Income
n/a n/a n/a n/a n/a n/a n/a n/a 0.52 n/a 3.59 n/a n/a n/a n/a n/a n/a n/a n/a 1.71K
Pretax Income
-1.14M -1.04M -1.36M -974K -851.53K -2.66M -2.91M -3.53M -3.31M -5.43M -3.11M -3.04M -3.87M -2.57M -3.6M -2.32M -1.26M -1.12M -1.35M -1.32M
Net Income
-1.14M -1.04M -1.36M -974K -851.53K -2.66M -2.91M -3.53M -3.31M -5.43M -3.11M -3.04M -3.87M -2.57M -3.6M -2.32M -1.26M -1.12M -1.35M -1.32M
Selling & General & Admin
688.78K 590.3K 1.05M 755.83K 666.63K 738.49K 904.94K 1.16M 1.66M 2.54M 1.57M 1.66M 2.21M 1.68M 1.83M 1.39M 927.28K 881.4K 823.03K 1.01M
Research & Development
450.16K 447.11K 311.09K 206.57K 183.43K 1.91M 2M 2.37M 1.65M 2.89M 1.53M 1.38M 1.66M 873.65K 1.75M 916.41K 292.69K 234.26K 474.91K 308.85K
Other Expenses
n/a -415 -88 n/a 0.00 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
1.14M 1.04M 1.36M 962.4K 837.38K 2.65M 2.9M 3.53M 3.31M 5.42M 3.11M 3.04M 3.87M 2.56M 3.58M 2.31M 1.22M 1.12M 1.3M 1.32M
Interest Expense
509.00 2.02K 3.5K 12.01K 1.47K 2.49K 4.31K 1.83K 519.00 2.06K 3.59K 1.53K 602.00 16.3K 15.99K 13.63K 36.86K 65.64K 56.15K 151.00
Selling & Marketing Expenses
3.29K n/a 304K n/a n/a -12.69K n/a 247.33K 247.33K 247.33K 247.33K n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
1.14M 1.04M 1.36M 962.4K 850.07K 2.66M 2.9M 3.53M 3.31M 5.42M 3.11M 3.04M 3.87M 2.56M 3.58M 2.31M 1.22M 1.12M 1.3M 1.32M
Income Tax Expense
n/a n/a n/a n/a -2 -5 n/a -30.59K -7.18K n/a 3.59K 1.53K -3.4K n/a n/a n/a n/a n/a n/a n/a
Shares Outstanding (Basic)
778.73K 5.52M 3.53M 777.82K 3.44M 705.43K 3.28M 3.28M 3.23M 3.27M 3.25M 3.25M 2.93M 3.13M 3.12M 2.77M 2.46M 2.4M 2.4M 2.4M
Shares Outstanding (Diluted)
778.73K 5.52M 3.53M 777.82K 3.44M 705.43K 3.28M 3.28M 3.23M 3.28M 3.25M 3.25M 2.93M 3.14M 3.12M 2.77M 2.46M 2.41M 2.41M 2.41M
EPS (Basic)
-2.22 -0.19 -0.4 -1.25 -1.24 -3.77 -4.43 -5.38 -5.12 -8.3 -4.8 -4.5 -6.6 -4.5 -5.78 -0.84 -2.55 -1.87 -2.26 -2.2
EPS (Diluted)
-2.22 -0.19 -0.4 -1.25 -1.24 -3.77 -4.43 -5.38 -5.12 -8.3 -4.8 -4.5 -6.6 -4.5 -6 -0.84 -2.55 -1.87 -2.26 -2.2
EBITDA
-1.13M -1.02M -1.34M -950K -837.38K -2.65M -2.89M -3.51M -3.3M -5.42M -3.1M -3.03M -3.87M -2.56M -3.58M -2.31M -1.22M -1.05M -1.3M -1.32M
EBIT
-1.14M -1.04M -1.36M -962K -850.07K -2.66M -2.9M -3.53M -3.31M -5.42M -3.11M -3.04M -3.87M -2.56M -3.58M -2.31M -1.22M -1.05M -1.3M -1.32M
Depreciation & Amortization
12.69K 12.69K 12.69K 12.69K 12.69K 12.69K 12.69K 12.69K 5.32K 5.32K 5.32K 7.1K 887.00 1.13M 1.28M 2.31M 1.22M 1.12M 1.3M 1.32M